Updates are available Correction dated 2026-09-23
Click to view Correction: https://doi.org/10.1007/s40121-026-01445-x
-
Authors
Li, Zhenwei
Gu, Shenjia
Li, Jiajun
Li, Guomin
Wu, Zheng
Lin, Hongbo
Chen, Kan
Xu, Zhexin
Fu, Chuanxi https://orcid.org/0000-0003-3458-8386
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA (14302)
- License Information
-
More Information
Article History
Received: 3 December 2025
Accepted: 20 January 2026
First Online: 4 February 2026
Change Date: 25 September 2026
Change Type: Update
Change Details: The original online version of this article was revised: the author’s name Guomin Li was incorrectly written as Guomin Zhang.
Change Date: 23 September 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-026-01445-x
Declarations
Conflict of Interest: The authors, including Zhenwei Li, Shenjia Gu, Jiajun Li, Guomin Li, Zheng Wu, Hongbo Lin, Kan Chen, Zhexin Xu and Chuanxi Fu, declare that they have no conflicts of interest.
Ethical Approval: The study protocol was reviewed and approved by the Ethics Committee of Zhejiang Chinese Medical University (approval no. AF-20220921-1). This study utilised de-identified data from existing databases and was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent amendments. As this was a database-based study, the requirement for patient consent was waived by the institutional review board.
